Luan M. Streb

Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial

Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa